Efficacy and Safety of Tolebrutinib (SAR442168) Tablets in Adult Participants With Generalized Myasthenia Gravis
Clinical trial NCT05132569 · TERMINATED
Trial details
- NCT number
- NCT05132569
- Sponsor
- Sanofi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-02-21
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.